esmo 2020 highlights on neoadjuvant mfolfirinox for t3-4 rectal cancer: the prodige 23 study
Published 4 years ago • 3.5K plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
2:27
esmo 2020 highlights on neoadjuvant ici in early tnbc: the impassion031 study
-
2:46
#esmo22 highlights on neoadjuvant ici in locally advanced dmmr colon cancer: the niche-2 study
-
9:55
asco 2023 expert report on novelties in the treatment of colorectal cancer by s. stintzing
-
8:34
neoadjuvant chemo with mfolfirinox shows survival benefit in locally advanced rectal cancer
-
6:37
highlights from esmo 2020 in gynecological cancers
-
1:06
esmo 2021 highlights in colorectal cancer
-
1:00
esmo 2022 highlights
-
0:11
life of young colon cancer survivor
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
1:31
esmo oncologypro - intro by prof. a. matikas
-
1:19
targeted therapies for patients with her2 colorectal cancer
-
2:33
early colon and rectal cancer at esmo wcgic 2021
-
0:47
from stage iv colon cancer diagnosis to survivorship
-
0:18
achieving the esmo vision 2020, and looking beyond
-
1:21
esmo essentials for clinicians: gastrointestinal tract tumours - 2nd edition
-
9:49
esmo's most important colorectal cancer trials with david kerr
-
7:22
total neoadjuvant therapy with mfolfirinox versus preoperative chemoradiation in patients with l...
-
0:55
esmo 2022 highlights